Börse:

MEI Pharma

[WKN: A1KATX | ISIN: US55279B2025]

0,241$ 0,42%

Echtzeit-Aktienkurs MEI Pharma

Bid: Ask:

Nachrichten zur MEI Pharma Aktie

» Nachrichtenticker öffnen

Avalyn Announces Upcoming Presentations on its Lead Program AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis at the European Respiratory Society International Congress 2024

CAMBRIDGE, Mass., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development…

MEI Pharma enrolls expansion cohort in leukemia study By Investing.com

MEI Pharma enrolls expansion cohort in leukemia study…

FSD Pharma Signs Agreement With Ingenu CRO to Conduct a Clinical Trial To Determine the Safety and Efficacy Effects of its Proprietary Blend Beverage unbuzzd(TM)

FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets…

‹
1
›